Get started
Author

Jörg Schüttrumpf

Observed names: J Schüttrumpf, J. SCHUETTRUMPF, J. Schüttrumpf, J., Schüttrumpf, Joerg Schuettrumpf, Jörg Schüttrumpf, Schüttrumpf, Jörg
Institution: Grifols (Spain)
Observed institutions: University of North Carolina at Chapel Hill, Goethe University Frankfurt, University of Vienna, Children's Hospital of Philadelphia, Howard Hughes Medical Institute, German Red Cross, Biotest (Germany), Grifols (Spain), University Hospital Frankfurt, Georg Speyer Haus, DRK-Blutspendedienst Baden-Württemberg - Hessen, University of Pennsylvania
ORCID: 0000-0002-8855-4096
Observed ORCID: 0000-0002-8855-4096
OpenAlex ID: A5111970085
Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1
2003 · Valder R. Arruda, Joerg Schuettrumpf, et al. · Blood · 151
Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)
2018 · Tobias Welte, R. Phillip Dellinger, et al. · Intensive Care Medicine · 138
PDF
Galectin-9 Is a Suppressor of T and B Cells and Predicts the Immune Modulatory Potential of Mesenchymal Stromal Cell Preparations
2013 · Christopher Ungerer, Patricia Quade-Lyssy, et al. · Stem Cells and Development · 109
Factor IX variants improve gene therapy efficacy for hemophilia B
2004 · Joerg Schuettrumpf, Roland W. Herzog, et al. · Blood · 74
Improved Hepatic Gene Transfer by Using an Adeno-Associated Virus Serotype 5 Vector
2002 · Federico Mingozzi, Jörg Schüttrumpf, et al. · Journal of Virology · 72
Factor V Leiden improves in vivo hemostasis in murine hemophilia models
2005 · A. SCHLACHTERMAN, J. SCHUETTRUMPF, et al. · Journal of Thrombosis and Haemostasis · 69
Inadvertent Germline Transmission of AAV2 Vector: Findings in a Rabbit Model Correlate with Those in a Human Clinical Trial
2006 · Joerg Schuettrumpf, Jian-Hua Liu, et al. · Molecular Therapy · 66
PDF
Specific gene delivery to liver sinusoidal and artery endothelial cells
2013 · Tobias Abel, Ebtisam El Filali, et al. · Blood · 55
Increased Prevalence of a Polymorphism in the Gene Coding for Human Prothrombin in Patients With Coronary Heart Disease
1997 · H.H. Watzke, J. Schüttrumpf, et al. · Thrombosis Research · 53
Chemical Chaperones Improve Protein Secretion and Rescue Mutant Factor VIII in Mice with Hemophilia A
2012 · Stefanie D. Roth, Jörg Schüttrumpf, et al. · PLoS ONE · 44
PDF
Tregalizumab – A Monoclonal Antibody to Target Regulatory T Cells
2016 · Martin König, Faiza Rharbaoui, et al. · Frontiers in Immunology · 40
PDF
A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway
2014 · Bianca Helling, Martin König, et al. · Immunology and Cell Biology · 40
PDF
Pneumolysin induces platelet destruction, not platelet activation, which can be prevented by immunoglobulin preparations in vitro
2020 · Kristin Jahn, Stefan Handtke, et al. · Blood Advances · 36
PDF
Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice
2011 · Peter Milanov, Lacramioara Ivanciu, et al. · Blood · 33
PDF
Novel hemophilia B mouse models exhibiting a range of mutations in the Factor IX gene
2004 · Denise E. Sabatino, Elina Armstrong, et al. · Blood · 31
Serial Monitoring and Hyperimmunoglobulin versus Standard of Care to Prevent Congenital Cytomegalovirus Infection: A Phase III Randomized Trial
2021 · Roland Devlieger, Horst Buxmann, et al. · Fetal Diagnosis and Therapy · 29
PDF
Functional relevance of in vivo half antibody exchange of an IgG4 therapeutic antibody-drug conjugate
2018 · Peter Herbener, Kurt Schönfeld, et al. · PLoS ONE · 26
PDF
Functional Properties of Human Cytomegalovirus Hyperimmunoglobulin and Standard Immunoglobulin Preparations
2016 · Matthias Germer, Peter Herbener, et al. · Annals of Transplantation · 24
Activity of Indatuximab Ravtansine against Triple-Negative Breast Cancer in Preclinical Tumor Models
2018 · Kurt Schönfeld, Peter Herbener, et al. · Pharmaceutical Research · 23
PDF
Transgene Loss and Changes in the Promoter Methylation Status as Determinants for Expression Duration in Nonviral Gene Transfer for Factor IX
2010 · Jörg Schüttrumpf, Peter Milanov, et al. · Human Gene Therapy · 23
Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI
2021 · Fabian Bohländer, Dennis Riehl, et al. · Frontiers in Immunology · 22
PDF
The inhibitory effects of anticoagulation on in vivo gene transfer by adeno-associated viral or adenoviral vectors
2005 · Joerg Schuettrumpf, Jianxiang Zou, et al. · Molecular Therapy · 20
PDF
The immunomodulating activity of trimodulin (polyvalent IgM, IgA, IgG solution): a post hoc analysis of the phase II CIGMA trial
2023 · Mervyn Singer, Antoni Torres, et al. · Critical Care · 19
PDF
The Dual Role of a Polyvalent IgM/IgA-Enriched Immunoglobulin Preparation in Activating and Inhibiting the Complement System
2021 · Carolin Schmidt, Sabrina Weißmüller, et al. · Biomedicines · 19
PDF
Oral gene therapy for hemophilia B using chitosan‐formulated FIX mutants
2014 · P. Quade‐Lyssy, P. Milanov, et al. · Journal of Thrombosis and Haemostasis · 19
PDF
Works count: 66
Citation count: 1,412
H-index: 21
I10-index: 33
Year
Topic
Type